Omnicals Pharma Private Limited, a active private limited company, was established on 17 May 2017 in Mumbai, Maharashtra, India. Engaging in business & it consulting within the hospital and medical care sector, it holds CIN: U33309MH2017PTC294976. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹2.08 M.
It upholds a compliant status. Employing 14 professional, Its leadership includes Rohit Dansingh Negi (Director), Anurag Bhoop Narayan Pathak (Managing Director), Anil Kashiram Fokmare (Director). Past directors included Anurag Bhoop Narayan Pathak, Nidhi Anurag Pathak, Santosh Kumar Rai. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No 43, Raheja Bldg, 2B Windermere, Oshiwara Link Road, Near Mhada, Lokhanwalla, Andh, Eri West,, Mumbai, Maharashtra, 400053.
U33309MH2017PTC294976
294976
17 May 2017
₹1.00 Cr
₹2.08 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Omnicals Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Dansingh Negi | Director | 17 May 2017 | Current |
| Anurag Bhoop Narayan Pathak | Managing Director | 08 Aug 2017 | Current |
| Anil Kashiram Fokmare | Director | 15 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 08 Nov 2023 | Past |
| Pramod Abcsdd | Director | 15 Dec 2018 | Past |
| Pramod Abcsdd | Director | 07 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 08 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omnicals Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 19.01% decrease. The company also saw a slight improvement in profitability, with a 7.1% increase in profit. The company's net worth Soared by an impressive increase of 78.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Omnicals Pharma had a promoter holding of 89.55% and a public holding of 10.45%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Omnicals Pharma has a workforce of 14 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Omnicals Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omnicals Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Omnicals Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Omnicals Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Anil Kashiram Fokmare was appointed as a Director was appointed as a Director on 15 Dec 2022 & has been associated with this company since 2 years 11 months . was completed.
Anurag Bhoop Narayan Pathak was appointed as a Managing Director was appointed as a Managing Director on 08 Aug 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
Rohit Dansingh Negi was appointed as a Director was appointed as a Director on 17 May 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
The activity Omnicals Pharma Private Limited was registered on 17 May 2017 with Roc Mumbai & aged 8 years 6 months as per MCA records. was completed.
The CIN of Omnicals Pharma Private Limited is U33309MH2017PTC294976.
Omnicals Pharma Private Limited is headquartered at Flat No 43, Raheja Bldg, 2B Windermere, Oshiwara Link Road, Near Mhada, Lokhanwalla, Andh, Eri West,, Mumbai, Maharashtra, 400053.
Omnicals Pharma Private Limited was incorporated on 17 May 2017.
The current directors of Omnicals Pharma Private Limited are
The primary industry of Omnicals Pharma Private Limited is Hospital And Medical Care.
Omnicals Pharma Private Limited is unlisted.
The authorized capital of Omnicals Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹2.08 M.
The compliance status of Omnicals Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX